Nuzenio

Tradingview Arrowhead Pharmaceuticals

Tradingview Arrowhead Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Arrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingViewTradingView · Wed, 05 Aug 2026 09:20:04 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:01:32 GMTArrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $105.4, Implies 23% Upside - TradingViewTradingView · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Wed, 05 Aug 2026 09:20:04 GMTArrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $110.2, Implies 23% Upside - TradingView
Tue, 04 Aug 2026 22:03:56 GMTArrowhead Pharmaceuticals Q3 Earnings Call Highlights - TradingView
Tue, 04 Aug 2026 21:01:32 GMTArrowhead Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Tue, 28 Jul 2026 07:00:00 GMTArrowhead Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $105.4, Implies 23% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Arrowhead Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.